[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "(650) 407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 54, "title": "CEO & Chair", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1080000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 53, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 77, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0951, "open": 0.3351, "dayLow": 0.0951, "dayHigh": 0.0951, "regularMarketPreviousClose": 0.0951, "regularMarketOpen": 0.3351, "regularMarketDayLow": 0.0951, "regularMarketDayHigh": 0.0951, "payoutRatio": 0.0, "beta": 0.32, "volume": 34572497, "regularMarketVolume": 34572497, "averageVolume": 2473244, "averageVolume10days": 14092220, "averageDailyVolume10Day": 14092220, "bid": 0.078, "ask": 0.1153, "bidSize": 2, "askSize": 2, "marketCap": 177375, "fiftyTwoWeekLow": 0.062, "fiftyTwoWeekHigh": 896.0, "allTimeHigh": 25600.0, "allTimeLow": 0.062, "fiftyDayAverage": 4.0517, "twoHundredDayAverage": 13.80569, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6569022, "forwardPE": -0.025702702, "profitMargins": 0.0, "floatShares": 1179980, "sharesOutstanding": 1865147, "sharesShort": 192892, "sharesShortPriorMonth": 106183, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1034, "heldPercentInsiders": 0.01727, "heldPercentInstitutions": 0.16631001, "shortRatio": 0.83, "shortPercentOfFloat": 0.105, "impliedSharesOutstanding": 1865150, "bookValue": -8.544, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -41912760, "trailingEps": -8.02, "lastSplitFactor": "1:20", "lastSplitDate": 1749772800, "enterpriseToEbitda": -0.394, "52WeekChange": -0.99973977, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 0.0951, "targetHighPrice": 30.0, "targetLowPrice": 30.0, "targetMeanPrice": 30.0, "targetMedianPrice": 30.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 3302674, "totalCashPerShare": 2.74, "ebitda": -16679652, "totalDebt": 1152618, "quickRatio": 0.434, "currentRatio": 0.557, "returnOnAssets": -1.56888, "freeCashflow": -8613463, "operatingCashflow": -13367386, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2025-11-07", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638282600000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.0951 - 0.0951", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2473244, "fiftyTwoWeekLowChange": 0.0331, "fiftyTwoWeekLowChangePercent": 0.533871, "fiftyTwoWeekRange": "0.062 - 896.0", "fiftyTwoWeekHighChange": -895.9049, "fiftyTwoWeekHighChangePercent": -0.99989384, "fiftyTwoWeekChangePercent": -99.973976, "epsTrailingTwelveMonths": -8.02, "epsCurrentYear": -15.39, "priceEpsCurrentYear": -0.006179337, "fiftyDayAverageChange": -3.9566002, "fiftyDayAverageChangePercent": -0.9765284, "twoHundredDayAverageChange": -13.710589, "twoHundredDayAverageChangePercent": -0.9931115, "priceToBook": -0.011130619, "marketState": "CLOSED", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0951, "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "corporateActions": [{"header": "Delisting", "message": "CERO was delisted effective Oct. 31, 2025", "meta": {"eventType": "DELISTING", "dateEpochMs": 1761886800000}}], "regularMarketTime": 1761854402, "displayName": "CERo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]